Medtronic plc — Key Metrics
3 years of history · ending 2025-04-25 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
M-Score (Beneish; >-1.78 flags risk)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$4
Book Value Per Share
$37
Free Cash Flow Per Share
$4
Cash Per Share
$2
Revenue Per Share
$26
OCF Per Share
$5
Return on Equity
9.5%
Return on Assets
5.1%
Return on Invested Capital
10.1%
Debt to Equity
—
Current Ratio
1.85
Quick Ratio
1.42
Asset Turnover
0.37
Days Sales Outstanding
70.91
Days Payables Outstanding
76.85
Days Inventory On Hand
171.83
Cash Conversion Cycle
165.89
R&D / Revenue
8.1%
SBC / Revenue
1.3%
Capex / Revenue
5.5%
Working Capital
$10.94B
Net Current Asset Value
$-19.61B
Invested Capital
$48.02B
OCF / Net Income
1.51
FCF / Net Income
1.11
Accruals Ratio (Sloan)
-2.6%
Net Debt
$-6.09B
Net Debt / EBITDA
-0.69
Interest Coverage
8.17
Cash Coverage
9.66
Dividend Coverage
1.96
Capex Coverage
3.79
Tangible Common Equity
$-5.38B
TCE / Total Assets
-5.9%
Goodwill / Total Assets
45.5%
NOPAT
$4.96B
Cash ROIC
10.5%
WC / Revenue
32.6%
Capex / D&A
0.65
Reinvestment Rate
-15.2%
Total Payout Ratio
146.4%
Asset Growth vs Revenue Growth
-1.7%
Revenue 5Y CAGR
3.0%
EPS 5Y CAGR
-0.5%
FCF 5Y CAGR
-2.9%
EBITDA 5Y CAGR
3.4%
Book Value 5Y CAGR
-1.1%
Stock Price (FY-end)
$82
Market Cap
$105.21B
P/E Ratio
22.57
P/S Ratio
3.14
P/B Ratio
2.19
P/OCF Ratio
14.94
P/FCF Ratio
20.29
Enterprise Value
$99.12B
EV / EBITDA
11.24
EV / Sales
2.96
EV / FCF
19.12
FCF Yield
4.9%
Dividend Yield
3.4%
Shareholder Yield
6.1%
Buyback Yield
3.1%
R&D Yield
2.6%
Capex Yield
1.8%
Dividend Per Share
$3
DPS YoY Growth
1.0%
Operating Leverage
4.35
Graham Number
$55
Shares Variation (YoY)
-3.0%
Beta (5Y)
0.65
Cost of Equity
7.7%
Cost of Debt (after tax)
21.1%
WACC
—
ROIC - WACC Spread
—
52W High
$91
52W Low
$73
Trailing Return 1Y
7.0%
Trailing Return 5Y
-0.5%
F-Score (Piotroski)
6.00
M-Score (Beneish)
-3.07
Z-Score (Altman)
2.66
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.